NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SonoThera

SonoThera

Private
South San Francisco, CaliforniaHealthcare & Life Scienceshttps://sonothera.com/

Last Round

Series B

Jun 10, 2026

Total Funding Raised

$185.75M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

SonoThera is a biotechnology company that develops ultrasound-guided nonviral gene therapy platforms to treat the root causes of human diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

non-viral gene therapyultrasound-mediated deliverygenetic medicinemicrobubble technologygene delivery platformbiotech platformtargeted gene therapydrug delivery systempayload engineeringgenetic disorder treatmentclinical-stage biotechnext-gen gene therapyviral vector alternativebiopharma licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SonoThera Comparables

Compare SonoThera with similar companies based on industry and business-model similarity.

SonoThera comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BreezeBio
81%
Danaher
74%
Aera Therapeutics
74%

SonoThera Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJun 10, 2026
Series ADec 5, 2022

Key People

Founding team and executive leadership

Kenneth Greenberg

Co-Founder And CEO At SonoThera

Founding Team

SonoThera Investors

Notable investors and investment history

SonoThera investors
InvestorRounds
Lifespan Financial PlanningSeries A
UCB VenturesSeries B
SymBiosis Capital ManagementSeries B
RA Capital ManagementSeries B
Vertex Ventures HCSeries B, Series A
CureDuchenne VenturesSeries B
ARCH Venture PartnersSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 10, 2026

    $125M round closed.

  • Mar 5, 2026

    Presented preclinical data on RIPPLE(TM) platform for Duchenne muscular dystrophy at MDA 2026.

SonoThera Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SonoThera Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SonoThera's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouth San Francisco, California
Employee Range56
Year Founded2022
Last FundingJun 10, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.